Eli Lilly has not said why it is seeing this shortage The shortage will only affect vials of insulin, not the pens, which doctors hope will help alleviate some of the panic people may be experiencing.

After years of preparation, Eli Lilly is on the brink of launching ... The Tempo system brings together a pre-filled insulin pen, the TempoSmart app and a recently-approved Smart Button device ...

Drug company Eli Lilly announced it will cut the price of its insulin by 70 percent. How much will the drug cost and what does this mean for people with diabetes? Here's everything you need to ...

Two years ago, Eli Lilly started working with Dexcom ... app-based remote monitoring and alarm functions – in pen- and pump-based insulin systems that form the basis of the drugmaker’s ...

The global insulin delivery pen market is poised for remarkable growth, with its valuation projected to increase from USD ...

In 2023, the global disposable pen injectors market is expected to be worth USD 25.5 billion. The market is expected to reach USD 54.4 billion by 2033, expanding at a 7.9% CAGR throughout the forecast ...

Drug giant Eli Lilly has announced a $35 (£30) cap on the monthly costs patients face for insulin in the US, responding to outcry over the soaring cost of the diabetes medication. More than eight ...

According to the American Diabetes Association, approximately 8.4 million people in the United States need insulin to survive ...

The official spokesperson for the Ministry of Health and Population Hossam Abdel-Ghaffar announced details on the extended-release for the first locally produced batch of insulin “Glargine”, in ...

The Egyptian Drug Authority approved the insulin glargine injection manufactured by EVA Pharma through a collaboration with Eli Lilly (LLY). Launched in 2022, the collaboration aims to deliver a ...